Trimetazidine improves hepatic lipogenesis and steatosis in non‑alcoholic fatty liver disease via AMPK‑ChREBP pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trimetazidine improves hepatic lipogenesis and steatosis in non‑alcoholic fatty liver disease via AMPK‑ChREBP pathway

Published:2020-07-08 Issue:3 Volume:22 Page:2174-2182
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Zhang Ying¹,Li Can²,Li Xiuqi¹,Wu Cheng³,Zhou Haiyan⁴,Lu Shuang²,Liu Xingde⁵

Affiliation:

1. Department of Cardiology, General Hospital of The Yangtze River Shipping, Wuhan, Hubei 430010, P.R. China

2. Department of Infectious Diseases, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China

3. Department of Cardiology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China

4. Department of Clinical Research Centre, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China

5. Department of Cardiology, The Second Clinical Medical College of Guiyang College of Chinese Medicine, Guiyang, Guizhou 550004, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Forkhead box O1 in metabolic dysfunction-associated fatty liver disease: molecular mechanisms and drug research;Frontiers in Nutrition;2024-07-02

2. Biochemical Aspects That Lead to Abusive Use of Trimetazidine in Performance Athletes: A Mini-Review;International Journal of Molecular Sciences;2024-01-28

3. 6-Methyl flavone inhibits Nogo-B expression and improves high fructose diet-induced liver injury in mice;Acta Pharmacologica Sinica;2023-07-04

4. Trimetazidine as a modifier of doxorubicin+cyclophosphamideinduced hyperdyslipidemia;The Siberian Journal of Clinical and Experimental Medicine;2022-07-15

5. Sirtuin 6 affects glucose reabsorption and gluconeogenesis in type 1 diabetes via FoxO1;Molecular and Cellular Endocrinology;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3